When should prophylactic treatment in patients with haemophilia A and B start? - The German experience

Haemophilia

Volumn 4, Issue 4, 1998, Pages 413-417

  Kreuz, W ^a   Escuriola Ettingshausen, C ^a   Funk, M ^a   Schmidt, H ^a   Kornhuber, B ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Haemophilia A and B; Haemophilic arthropathy; Joint bleeding; Joint status; Outcome; Prophylaxis

Indexed keywords

BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 9 CONCENTRATE;

ADOLESCENT; ADULT; ANKLE; ARTHROPATHY; CLINICAL ARTICLE; CONFERENCE PAPER; DISEASE SEVERITY; ELBOW; HEMARTHROSIS; HEMOPHILIA A; HEMOPHILIA B; HUMAN; KNEE; MALE; ONSET AGE; PRIORITY JOURNAL; PROPHYLAXIS; RADIODIAGNOSIS; SCHOOL CHILD; SCORING SYSTEM;

EID: 0031876988     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.1998.440413.x     Document Type: Conference Paper

References (15)

1. Nilsson IM, Berntorp E, Lofqvist T, Pettersson H. Twentyfive years' experience of prophylactic treatment in severe haemophilia A and B. J Intern Med 1992; 232 (1): 25-32.
2. Lofqvist T, Nilsson IM, Berntorp E, Pettersson H. Haemophilia prophylaxis in young patients - a long-term follow-up. J Intern Med 1997; 241(5): 395-400.
3. Aledort LM, Haschmeyer RH, Pettersson H. A longitudinal study of orthopaedic outcomes for severe factor VIII-deficient haemophiliacs. The Orthopaedic Outcome Study Group. J Intern Med 1994; 236(4): 391-9.
4. Dzinaj T, Funk M, Schmidt H, Böuger S, Güngör T, Klarmann D, Kreuz W. Radiological score in paediatric haemophilic patients with early and late onset of factor VIII prophylaxis. Thromb Haemost 1996; 76(4): 630-1.
5. Scheibel E. Experience with prophylaxis in Denmark. In: Prophylactic Treatment of Haemophilia A and B: Current and Future Perspectives. Nilsson IM, Berntorp E (eds.). New York: Science and Medicine, 1994; 21-22.
6. Manco-Johnson MJ, Nuss R, Geraghty S, Funk S, Kilcoyne R. Results of secondary prophylaxis in children with severe hemophilia. Am J Hematol 1994; 47: 113-7.
7. Ehrenfort h S, Kreuz W, Scharrer I, Linde R, Funk M, Güngör T, et al. Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs. Lancet 1992; 339 (8793): 594-8.
8. Kreuz W, Escuriola Ettingshausen C, Martinez Saguer I, Güngör T, Kornhuber B. Epidemiology of inhibitors in Haemophilia A. Vox Sang 1996; 70 (Suppl 1): 2-8.
9. Pettersson H, Ahlberg A, Nilsson IM. A radiological classification of hemophilic arthropathy. Clin Orthop 1980; 149: 153-9.
10. Pettersson C. Orthopaedic joint evaluation in Hemophilia. In: Prophylactic Treatment of Haemophilia A and B: Current and Future Perspectives. Nilsson IM, Berntorp E (eds.). New York: Science and Medicine, 1994; 35-9.
11. Langdell RD, Wagner RH, Brinkhous KM. Effect of anti-haemophilic factor on one-stage-clotting test: a presumptive test for haemophilia and a simple one-stage antihaemophilic factor assay procedure. J Lab Clin Med 1953; 41: 637-45.
12. Liesner RJ, Khair K, Hann IM. The impact of prophylactic treatment on children with severe haemophilia. Br J Haematol 1996; 92(4): 973-8.
13. Luck JV, Kasper CK. Surgical management of advanced hemophilic arthropathy. An overview of 20 years experience. Clin Orthop 1989; 242: 60-82.
14. Madhock R, Bennett D, Sturrock RD, Forbes CD. Mechanisms of joint damage in an experimental model of hemophilic arthritis, Arthitis Rheum 1988; 31: 1148-55.
15. Roy S, Ghadially FN. Pathology of experimental arthritis. Ann Rheum Dis 1966; 26: 402-15.